A patient receives ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting (CINV). The patient states that the drugs provide relief during and immediately after chemotherapy, but that significant nausea and vomiting occur several days after each chemotherapy treatment. What action will the prescriber take to address this outcome?

Question

Quizplus · Accepted Answer

Aprepitant is used to prevent delayed chemotherapy-induced nausea and vomiting (CINV), which occurs several days after treatment. Adding aprepitant to the regimen can help address symptoms that occur beyond the immediate post-chemotherapy period.

A Patient Receives Ondansetron and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting